102 related articles for article (PubMed ID: 26099629)
1. Lack of myeloid differentiation primary response protein MyD88 L265P mutation in primary cutaneous marginal zone lymphoma.
Brenner I; Roth S; Flossbach L; Wobser M; Rosenwald A; Geissinger E
Br J Dermatol; 2015 Dec; 173(6):1527-8. PubMed ID: 26099629
[No Abstract] [Full Text] [Related]
2. Myeloid differentiation primary response 88 mutations in a distinct type of cutaneous marginal-zone lymphoma with a nonclass-switched immunoglobulin M immunophenotype.
Wobser M; Maurus K; Roth S; Appenzeller S; Weyandt G; Goebeler M; Rosenwald A; Geissinger E
Br J Dermatol; 2017 Aug; 177(2):564-566. PubMed ID: 27861728
[No Abstract] [Full Text] [Related]
3. MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.
Martinez-Lopez A; Curiel-Olmo S; Mollejo M; Cereceda L; Martinez N; Montes-Moreno S; Almaraz C; Revert JB; Piris MA
Am J Surg Pathol; 2015 May; 39(5):644-51. PubMed ID: 25723115
[TBL] [Abstract][Full Text] [Related]
4. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.
Gachard N; Parrens M; Soubeyran I; Petit B; Marfak A; Rizzo D; Devesa M; Delage-Corre M; Coste V; Laforêt MP; de Mascarel A; Merlio JP; Bouabdhalla K; Milpied N; Soubeyran P; Schmitt A; Bordessoule D; Cogné M; Feuillard J
Leukemia; 2013 Jan; 27(1):183-9. PubMed ID: 22944768
[TBL] [Abstract][Full Text] [Related]
5. High Frequency of MYD88 L265P Mutation in Primary Ocular Adnexal Marginal Zone Lymphoma and Its Clinicopathologic Correlation: A Study From a Single Institution.
Behdad A; Zhou XY; Gao J; Raparia K; Dittman D; Green SJ; Qi C; Betz B; Bryar P; Chen Q; Chen YH
Arch Pathol Lab Med; 2019 Apr; 143(4):483-493. PubMed ID: 30444439
[TBL] [Abstract][Full Text] [Related]
6. MYD88 somatic mutations in MALT lymphomas.
Li ZM; Rinaldi A; Cavalli A; Mensah AA; Ponzoni M; Gascoyne RD; Bhagat G; Zucca E; Bertoni F
Br J Haematol; 2012 Sep; 158(5):662-4. PubMed ID: 22640364
[No Abstract] [Full Text] [Related]
7. High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type.
Pham-Ledard A; Beylot-Barry M; Barbe C; Leduc M; Petrella T; Vergier B; Martinez F; Cappellen D; Merlio JP; Grange F
JAMA Dermatol; 2014 Nov; 150(11):1173-9. PubMed ID: 25055137
[TBL] [Abstract][Full Text] [Related]
8. Some remarks on cutaneous marginal zone lymphoma.
Fernandez-Flores A
J Eur Acad Dermatol Venereol; 2008 May; 22(5):648-9. PubMed ID: 18363682
[No Abstract] [Full Text] [Related]
9. Cutaneous marginal zone lymphoma--still under study.
Delli FS
J Eur Acad Dermatol Venereol; 2008 May; 22(5):649-50. PubMed ID: 18363681
[No Abstract] [Full Text] [Related]
10. Detection of L265P MYD-88 mutation in a series of clonal B-cell lymphocytosis of marginal zone origin (CBL-MZ).
Kalpadakis C; Pangalis GA; Vassilakopoulos TP; Roumelioti M; Sachanas S; Korkolopoulou P; Koulieris E; Moschogiannis M; Yiakoumis X; Tsirkinidis P; Pontikoglou C; Rondoyianni D; Papadaki HA; Panayiotidis P; Angelopoulou MK
Hematol Oncol; 2017 Dec; 35(4):542-547. PubMed ID: 27734522
[TBL] [Abstract][Full Text] [Related]
11. Absence of MYD88 L265P mutation in blastic plasmacytoid dendritic cell neoplasm.
Fiandrino G; Arra M; Riboni R; Lucioni M; Dallera E; Arcaini L; Berti E; Paulli M
Br J Dermatol; 2013 Apr; 168(4):883-4. PubMed ID: 23013250
[No Abstract] [Full Text] [Related]
12. Is clinicopathological distinction of mucosa-associated lymphoid tissue lymphoma from Waldenström macroglobulinemia essential in MYD88 L265P mutation-positive cases?
Kidoguchi K; Kojima K; Seki R; Nagafuji K; Ohshima K; Kimura S
Int J Hematol; 2019 Mar; 109(3):247-248. PubMed ID: 30604315
[No Abstract] [Full Text] [Related]
13. Nodal marginal zone lymphoma: mutation status analyses of CD79A, CD79B, and MYD88 reveal no specific recurrent lesions.
Gurth M; Bernard V; Bernd HW; Schemme J; Thorns C
Leuk Lymphoma; 2017 Apr; 58(4):979-981. PubMed ID: 27687087
[No Abstract] [Full Text] [Related]
14. Significance of MYD88 L265P Mutation Status in the Subclassification of Low-Grade B-Cell Lymphoma/Leukemia.
Insuasti-Beltran G; Gale JM; Wilson CS; Foucar K; Czuchlewski DR
Arch Pathol Lab Med; 2015 Aug; 139(8):1035-41. PubMed ID: 26230596
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
Palmedo G; Hantschke M; Rütten A; Mentzel T; Kempf W; Tomasini D; Kutzner H
Am J Dermatopathol; 2007 Jun; 29(3):231-6. PubMed ID: 17519619
[TBL] [Abstract][Full Text] [Related]
16. Class-switched Primary Cutaneous Marginal Zone Lymphomas Are Frequently IgG4-positive and Have Features Distinct From IgM-positive Cases.
Carlsen ED; Swerdlow SH; Cook JR; Gibson SE
Am J Surg Pathol; 2019 Oct; 43(10):1403-1412. PubMed ID: 31464711
[TBL] [Abstract][Full Text] [Related]
17. MYD88 expression and L265P mutation in diffuse large B-cell lymphoma.
Choi JW; Kim Y; Lee JH; Kim YS
Hum Pathol; 2013 Jul; 44(7):1375-81. PubMed ID: 23380077
[TBL] [Abstract][Full Text] [Related]
18. Absence of MALT1 translocations in primary cutaneous marginal zone B-cell lymphoma.
Espinet B; Gallardo F; Pujol RM; Estrach T; Servitje O; Solé F
Haematologica; 2004 Sep; 89(9):ELT14. PubMed ID: 15377491
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological features and BRAF V600E and MYD88 L265P mutation status of nodal marginal zone lymphoma].
Wang XY; Li M; Zhao YX; Wang LF; Li DJ; Xu ZG; Kong LF
Zhonghua Bing Li Xue Za Zhi; 2022 Apr; 51(4):301-306. PubMed ID: 35359040
[No Abstract] [Full Text] [Related]
20. Lymphoplasmacytic lymphoma and marginal zone lymphoma in the bone marrow: paratrabecular involvement as an important distinguishing feature.
Bassarova A; Trøen G; Spetalen S; Micci F; Tierens A; Delabie J
Am J Clin Pathol; 2015 Jun; 143(6):797-806. PubMed ID: 25972321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
